Clinical outcomes of patients with acute lymphoblastic leukemia receiving the hyper-CVAD regimen and assessment of the risk of hepatitis flares due to hepatitis B virus reactivation after chemotherapy

Clinical outcomes of patients with acute lymphoblastic leukemia receiving the hyper-CVAD regimen and assessment of the risk of hepatitis flares due to hepatitis B virus reactivation after chemotherapy

Introduction Hyper-CVAD (hyperfractionated cyclophosphamide, vincristine, doxorubicin and dexamethasone) has become a popular regimen for adults with acute lymphoblastic leukemia (ALL). We assessed the efficacy and tolerability of hyper-CVAD in the treatment of adult ALL. Material and methods We re...

Full description

Bibliographic Details
Main Authors: Man Fai Law, Hay Nun Chan, Shun Yin Kong, Ho Kei Lai, Chung Yin Ha, Celia Ng, Yiu Ming Yeung, Sze Fai Yip
Format: Article
Language:English
Published: Termedia Publishing House 2021-03-01
Series:Archives of Medical Science
Subjects:
acute lymphoblastic leukemia
hepatitis b virus reactivation
hyper-cvad
Online Access:https://www.archivesofmedicalscience.com/Clinical-outcomes-of-patients-with-acute-lymphoblastic-leukemia-receiving-the-hyper,103606,0,2.html

Internet

https://www.archivesofmedicalscience.com/Clinical-outcomes-of-patients-with-acute-lymphoblastic-leukemia-receiving-the-hyper,103606,0,2.html

Similar Items